ARCHIVES

FDA Approves Iressa For Third-Line Treatment Of Non-Small Cell Lung Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 19 | May 9, 2003

Download PDF Visit The Full Archive

Related Articles

Proteomics Promises Ways To Track Response To Therapy

April 25, 2003

Diet & Nutrition Workshops Planned

March 14, 1975

In Brief: Online Genetics Glossary; ORI Misconduct Finding

February 5, 1999

Bisphosphonates May Reduce Recurrent Breast Cancer

December 25, 2009

Roche Markets CMV Test in Europe

April 29, 2011

‘Approval to Apply’ For Proton Facility Upgrade Denied

February 24, 1989